TELA

TELA Bio Inc

0.6540

Aug 24 • 3:59 PM ET +0.0077 (1.19%)

0.6450

Aftermarket • 5:35 PM ET -0.0090 (-1.38%)

Healthcare Medical Devices USA Nano NASD

Peers: ARAY BDMD ECOR ELUT LNSR NSPR SERA LUNG POAS MOBI

| Held by: VTI VXF

Index	-
Market Cap	29.37M
Enterprise Value	55.56M
Income	-41.18M
Sales	79.91M
Book/sh	-0.35
Cash/sh	0.68
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	218
IPO	Nov 08, 2019

P/E	-
Forward P/E	-
PEG	-
P/S	0.37
P/B	-
P/C	0.97
P/FCF	-
EV/EBITDA	-
EV/Sales	0.70
Quick Ratio	2.38
Current Ratio	2.99
Debt/Eq	-
LT Debt/Eq	-
Option/Short	Yes / Yes

EPS (ttm)	-0.77
EPS next Y	-0.51
EPS next Q	-0.15
EPS this Y	16.97%
EPS next Y	25.80%
EPS next 5Y	25.04%
EPS past 3/5Y	32.78% 17.97%
Sales past 3/5Y	24.68% 34.54%
EPS Y/Y TTM	30.65%
Sales Y/Y TTM	6.09%
EPS Q/Q	10.29%
Sales Q/Q	-4.49%
Earnings	Aug 10 AMC
EPS/Sales Surpr.	-15.07% -3.59%

Insider Own	27.67%
Insider Trans	0.22%
Inst Own	48.37%
Inst Trans	-5.66%
ROA	-64.71%
ROE	-616.62%
ROIC	-102.40%
Gross Margin	67.81%
Oper. Margin	-42.56%
Profit Margin	-51.53%
SMA20	-11.15%
SMA50	-13.70%
SMA200	-25.94%
Trades

Shs Outstand	44.83M
Shs Float	32.44M
Short Float	1.05%
Short Ratio	2.89
Short Interest	0.34M
52W High	2.00 -67.30%
52W Low	0.50 30.51%
Volatility	8.97% 12.71%
ATR (14)	0.09
RSI (14)	41.17
Beta	1.35
Rel Volume	17.52
Avg Volume	118.27K
Volume	2,071,702

Perf Week	0.62%
Perf Month	-5.35%
Perf Quarter	-26.53%
Perf Half Y	-14.62%
Perf YTD	-44.58%
Perf Year	-63.05%
Perf 3Y	-92.67%
Perf 5Y	-95.27%
Perf 10Y	-
Recom	1.40
Target Price	2.10
Prev Close	0.65
Price	0.65
Change %	1.19%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-21-25	Downgrade	Piper Sandler	Overweight → Neutral	$5 → $2
May-31-22	Initiated	Lake Street	Buy	$17
Dec-03-19	Initiated	Piper Jaffray	Overweight
Dec-03-19	Initiated	JMP Securities	Mkt Outperform
Dec-03-19	Initiated	Jefferies	Buy
Dec-03-19	Initiated	Canaccord Genuity	Buy

Aug-11-26 01:03AM	TELA Bio Inc (TELA) (Q2 2026) Earnings Call Highlights: Navigating PRS Headwinds and Strategic ... (GuruFocus.com) -15.05%
Aug-10-26 10:56PM	TELA Bio, Inc. Q2 2026 Earnings Call Summary (Moby) +6.91%
04:05PM	TELA Bio Reports Second Quarter 2026 Financial Results (GlobeNewswire)
Aug-07-26 09:24AM	Earnings To Watch: TELA Bio Inc (TELA) Q2 2026 -- GF Value Sees 97% Upside (GuruFocus.com)
Aug-05-26 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -6.01%
07:00AM	Loading…
Aug-04-26 07:00AM	TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director (GlobeNewswire) +22.51%
Jul-29-26 04:05PM	TELA Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference (GlobeNewswire)
Jul-20-26 04:05PM	TELA Bio to Announce Second Quarter 2026 Financial Results (GlobeNewswire)
May-13-26 08:30AM	TELA Bio, Inc. Q1 2026 Earnings Call Summary (Moby) -5.88%
01:01AM	TELA Bio Inc (TELA) Q1 2026 Earnings Call Highlights: Strong European Growth and Strategic U.S. ... (GuruFocus.com)
May-12-26 04:05PM	TELA Bio Reports First Quarter 2026 Financial Results (GlobeNewswire) +5.14%
May-11-26 09:23AM	What To Expect From TELA Bio Inc (TELA) Q1 2026 Earnings (GuruFocus.com)
May-07-26 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +11.11% -7.27%
Apr-30-26 04:43PM	TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues (GlobeNewswire) +13.07%
Apr-21-26 04:05PM	TELA Bio to Announce First Quarter 2026 Financial Results (GlobeNewswire)
08:30AM	Loading…
Mar-25-26 08:30AM	TELA Bio, Inc. Q4 2025 Earnings Call Summary (Moby) -9.35%
Mar-24-26 11:02PM	TELA Bio Inc (TELA) Q4 2025 Earnings Call Highlights: Record Revenue Growth Amid Strategic ... (GuruFocus.com) -8.27%
04:05PM	TELA Bio Reports Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
Mar-23-26 09:23AM	TELA Bio Inc (TELA) Q4 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com) +6.66%
Mar-10-26 04:05PM	TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire) -7.35%
Mar-02-26 08:15AM	Astrana Health, Inc. (ASTH) Q4 Earnings and Revenues Surpass Estimates (Zacks)
Feb-26-26 12:15PM	Anika Therapeutics (ANIK) Q4 Earnings and Revenues Beat Estimates (Zacks)
Feb-20-26 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -9.76% +6.77%
Jan-23-26 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Dec-12-25 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Nov-19-25 08:30AM	TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire) -8.47%
Nov-17-25 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +14.08%
Nov-14-25 12:03AM	TELA Bio Inc (TELA) Q3 2025 Earnings Call Highlights: Revenue Growth and Strategic Expansions ... (GuruFocus.com) -9.97%
Nov-13-25 05:15PM	TELA Bio, Inc. (TELA) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
04:21PM	TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants (GlobeNewswire)
04:01PM	Loading…
04:01PM	TELA Bio Reports Third Quarter 2025 Financial Results and Refinancing and Upsizing of Credit Facility (GlobeNewswire)
Nov-12-25 08:30AM	Humacyte, Inc. (HUMA) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
07:36AM	TELA Bio Inc (TELA) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Nov-05-25 07:10PM	Cytek Biosciences, Inc. (CTKB) Reports Q3 Loss, Tops Revenue Estimates (Zacks) -6.98%
Nov-04-25 08:30AM	TELA Bio to Announce Third Quarter 2025 Financial Results (GlobeNewswire) -5.84%
Nov-03-25 04:05PM	TELA Bio Appoints William Plovanic to Board of Directors (GlobeNewswire) +11.38%
Oct-09-25 04:05PM	TELA Bio Announces Addition of Betty Jo Rocchio to Board of Directors and the Departure of Director Lisa Colleran (GlobeNewswire)
Aug-12-25 03:06AM	TELA Bio Inc (TELA) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... (GuruFocus.com) -13.98%
Aug-11-25 07:00PM	TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates (Zacks) +8.14%
04:03PM	TELA Bio Reports Second Quarter 2025 Financial Results (GlobeNewswire)
Aug-08-25 05:00PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
09:31AM	TELA Bio Inc (TELA) Q2 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Aug-07-25 09:10AM	Prime Medicine, Inc. (PRME) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
Aug-06-25 08:15AM	Geron (GERN) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -8.11%
Jul-29-25 08:15AM	NeoGenomics (NEO) Meets Q2 Earnings Estimates (Zacks)
Jul-23-25 04:03PM	TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference (GlobeNewswire)
Jul-21-25 04:03PM	TELA Bio to Announce Second Quarter 2025 Financial Results (GlobeNewswire) -7.04%
Jun-07-25 11:01PM	Aroa Biosurgery Ltd (AROAF) (FY25) Earnings Call Highlights: Surpassing Revenue Expectations ... (GuruFocus.com)
Jun-06-25 04:05PM	TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jun-03-25 04:05PM	TELA Bio Announces European Commercial Launch of OviTex Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair (GlobeNewswire) +10.56% +19.75%
Jun-02-25 08:30AM	TELA Bio Appoints Jeffrey Blizard as President (GlobeNewswire)
May-22-25 04:05PM	TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference (GlobeNewswire)
May-09-25 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +9.04% -6.48%
03:41AM	TELA Bio Inc (TELA) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Challenges (GuruFocus.com)
May-08-25 05:45PM	TELA Bio, Inc. (TELA) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	TELA Bio Reports First Quarter 2025 Financial Results (GlobeNewswire)
May-07-25 11:43AM	TELA Bio Inc (TELA) Q1 2025 Earnings Report Preview: What to Expect (GuruFocus.com)
Apr-21-25 04:28PM	TELA Bio Inc (TELA) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges with ... (GuruFocus.com) -6.92% +5.62%
Apr-17-25 04:05PM	TELA Bio to Announce First Quarter 2025 Financial Results (GlobeNewswire)
Mar-31-25 07:00AM	TELA Bio Announces U.S. Commercial Launch of Larger Sizes of OviTex PRS for Plastic and Reconstructive Surgery (GlobeNewswire)
Mar-21-25 02:26PM	TELA Bio Shares Drop 43% After Weak Q4 Growth, High Sales Turnover (GuruFocus.com) -37.18%
12:05PM	Earnings To Watch: TELA Bio Inc (TELA) Reports Q4 2024 Result (GuruFocus.com)
Mar-20-25 10:05PM	TELA Bio sees 23-27% revenue growth for 2025 with expanded sales strategy (SeekingAlpha)
10:04PM	TELA Bio, Inc. (TELA) Q4 2024 Earnings Call Transcript (SeekingAlpha)
06:50PM	TELA Bio, Inc. (TELA) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
04:05PM	TELA Bio Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Feb-27-25 04:05PM	TELA Bio to Announce Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Feb-21-25 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jan-24-25 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Dec-13-24 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Nov-19-24 04:05PM	TELA Bio to Participate in Piper Sandler's 36th Annual Healthcare Conference (GlobeNewswire)
Nov-08-24 12:12PM	Q3 2024 TELA Bio Inc Earnings Call (Thomson Reuters StreetEvents)
02:29AM	TELA Bio Inc (TELA) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Nov-07-24 06:20PM	TELA Bio, Inc. (TELA) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:05PM	TELA Bio Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-06-24 07:49AM	What To Expect From TELA Bio Inc (TELA) Q3 2024 Earnings (GuruFocus.com)
Nov-01-24 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Oct-25-24 09:05PM	OrbiMed Advisors LLC Reduces Stake in TELA Bio Inc (GuruFocus.com) +10.85%
Oct-24-24 04:05PM	TELA Bio Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional Shares (GlobeNewswire)
Oct-23-24 08:07AM	TELA Bio Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants (GlobeNewswire) +6.43%
Oct-22-24 04:05PM	TELA Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants (GlobeNewswire)
Oct-17-24 04:05PM	TELA Bio to Announce Third Quarter 2024 Financial Results (GlobeNewswire)
Oct-01-24 09:02PM	Orbimed Advisors LLC Reduces Stake in TELA Bio Inc (GuruFocus.com)
Aug-12-24 05:20PM	TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates (Zacks) -22.94%
04:05PM	TELA Bio Reports Second Quarter 2024 Financial Results and Reiterates Full Year 2024 Revenue Guidance (GlobeNewswire)
Aug-09-24 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jul-25-24 04:05PM	TELA Bio to Participate in the Canaccord Genuity 44th Annual Growth Conference (GlobeNewswire)
Jul-22-24 04:05PM	TELA Bio to Announce Second Quarter 2024 Financial Results (GlobeNewswire)
Jun-04-24 04:05PM	TELA Bio Appoints Jeffrey Blizard to its Board of Directors (GlobeNewswire)
May-20-24 04:03PM	TELA Bio Appoints Greg Firestone as Chief Commercial Officer (GlobeNewswire)
May-13-24 11:01AM	TELA Bio, Inc. (NASDAQ:TELA) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-10-24 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +16.80%
03:51PM	TELA Bio Inc (TELA) Reports Q1 2024 Earnings: Revenue Surpasses Estimates Amidst Continued Growth (GuruFocus.com)
10:15AM	Piper Sandler Adjusts Price Target on TELA Bio to $10 From $12, Maintains Overweight Rating (MT Newswires)
May-09-24 04:05PM	TELA Bio Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-02-24 04:10PM	MiMedx Group, Inc. (NASDAQ:MDXG) Q1 2024 Earnings Call Transcript (Insider Monkey)
Apr-25-24 07:00AM	TELA Bio to Announce First Quarter 2024 Financial Results (GlobeNewswire)
Apr-15-24 07:00AM	TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex IHR - Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures (GlobeNewswire)
Apr-08-24 07:00AM	TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy (GlobeNewswire)
Mar-22-24 09:46AM	TELA Bio, Inc. (NASDAQ:TELA) Q4 2023 Earnings Call Transcript (Insider Monkey) +7.10%

TELA Bio, Inc. is a commercial stage medical technology company, which focuses on the design, development, and market of tissue reinforcement materials. The company was founded by Antony Koblish and Maarten Persenaire on April 17, 2012 and is headquartered in Malvern, PA.

PresidentMr. Jeffrey Blizard

CFOMr. Roberto E. Cuca J.D.

M.B.A.Ms. Heather C. Getz C.P.A.

VPMs. Megan Smeykal

Chief Technology OfficerMr. Paul Talmo

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Getz Heather C	Chief Executive Officer	Aug 17 '26	Buy	0.66	12,500	8,311	532,500	Aug 19 04:10 PM
Getz Heather C	Chief Executive Officer	Aug 14 '26	Buy	0.70	15,000	10,467	520,000	Aug 17 04:32 PM
EW HEALTHCARE PARTNERS FUND 2,	10% Owner	Nov 17 '25	Buy	1.11	3,604,000	4,000,440	7,714,709	Nov 17 04:26 PM

Open in Screener

MYO

Myomo Inc

1.39

Aug 24 • 3:59 PM ET -0.34 (-19.65%)

1.48

Aftermarket • 7:56 PM ET +0.09 (6.47%)

Healthcare Medical Devices USA Micro AMEX

Peers: LFWD VVOS NUWE NVNO ICCM MODD IRIX VTAK TNON NXL

| Held by: VTI VXF BUSM

Index	-
Market Cap	55.05M
Enterprise Value	61.68M
Income	-14.51M
Sales	43.26M
Book/sh	0.15
Cash/sh	0.34
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	195
IPO	Jun 12, 2017

P/E	-
Forward P/E	-
PEG	-
P/S	1.27
P/B	9.43
P/C	4.09
P/FCF	-
EV/EBITDA	-
EV/Sales	1.43
Quick Ratio	2.01
Current Ratio	2.31
Debt/Eq	3.44
LT Debt/Eq	3.24
Option/Short	Yes / Yes

EPS (ttm)	-0.34
EPS next Y	-0.24
EPS next Q	-0.08
EPS this Y	14.05%
EPS next Y	23.27%
EPS next 5Y	21.35%
EPS past 3/5Y	37.45% 36.74%
Sales past 3/5Y	38.05% 40.10%
EPS Y/Y TTM	-50.86%
Sales Y/Y TTM	6.14%
EPS Q/Q	15.44%
Sales Q/Q	21.26%
Earnings	Aug 05 AMC
EPS/Sales Surpr.	8.16% 13.06%

Insider Own	9.63%
Insider Trans	10.54%
Inst Own	36.91%
Inst Trans	-1.24%
ROA	-39.20%
ROE	-123.76%
ROIC	-58.66%
Gross Margin	68.35%
Oper. Margin	-27.05%
Profit Margin	-33.53%
SMA20	1.40%
SMA50	13.93%
SMA200	44.52%
Trades

Shs Outstand	39.53M
Shs Float	35.79M
Short Float	5.16%
Short Ratio	2.06
Short Interest	1.85M
52W High	1.88 -26.26%
52W Low	0.61 129.75%
Volatility	15.37% 13.13%
ATR (14)	0.18
RSI (14)	50.30
Beta	1.52
Rel Volume	1.04
Avg Volume	897.36K
Volume	934,573

Perf Week	-11.46%
Perf Month	43.30%
Perf Quarter	33.65%
Perf Half Y	101.16%
Perf YTD	52.75%
Perf Year	17.80%
Perf 3Y	85.33%
Perf 5Y	-86.47%
Perf 10Y	-
Recom	1.00
Target Price	4.54
Prev Close	1.73
Price	1.39
Change %	-19.65%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-31-24	Initiated	Craig Hallum	Buy	$7
May-20-24	Initiated	Lake Street	Buy	$7
Dec-15-23	Initiated	H.C. Wainwright	Buy	$6.50
Nov-11-20	Upgrade	ROTH Capital	Neutral → Buy	$5 → $7
May-27-20	Initiated	Dougherty & Company	Buy	$8.50
Oct-02-17	Initiated	H.C. Wainwright	Buy	$12

Aug-06-26 01:11AM	Myomo Inc (MYO) (Q2 2026) Earnings Call Highlights: Record Orders and Margin Expansion Drive ... (GuruFocus.com) +23.58%
Jul-29-26 04:05PM	Myomo to Report Second Quarter 2026 Financial Results on August 5 (Business Wire) +7.52%
Jun-16-26 04:05PM	Myomo Announces Participation in iAccess Alpha Virtual Best Ideas Summer Investment Conference (Business Wire) +13.33% -7.19%
May-20-26 07:30AM	Sidoti Events, LLC's May Micro-Cap Virtual Conference (ACCESSWIRE)
May-14-26 04:05PM	Myomo Announces Participation in Upcoming Investor Conferences (Business Wire) +9.21%
04:05PM	Loading…
May-13-26 04:05PM	Myomo Appoints Joseph M. Manko to its Board of Directors (Business Wire)
May-07-26 08:47PM	Myomo, Inc. Q1 2026 Earnings Call Summary (Moby) -5.05%
04:05PM	Myomo Reports First Quarter 2026 Financial and Operating Results (Business Wire)
May-04-26 04:05PM	Myomo Announces Availability of MyoPro at Ottobock Care Clinics in the U.S. (Business Wire)
May-01-26 04:05PM	Myomo to Report First Quarter 2026 Financial Results on May 7 (Business Wire)
Apr-20-26 04:05PM	Myomo Introduces Myomo Mobile App to Enhance Clinical Workflow and Patient Engagement (Business Wire) -10.36%
Apr-16-26 04:05PM	Myomo Appoints William J Febbo to its Board of Directors (Business Wire) +8.19%
Mar-11-26 09:04PM	Myomo Inc (MYO) Q4 2025 Earnings Call Highlights: Record Revenue Amid Rising Expenses and ... (GuruFocus.com) +5.90%
Mar-09-26 05:35PM	Myomo, Inc. (MYO) Reports Q4 Loss, Tops Revenue Estimates (Zacks) -16.80%
04:06PM	Myomo Reports Fourth Quarter and Full Year 2025 Financial and Operating Results (Business Wire)
04:05PM	Loading…
04:05PM	Myomo and Elevance Health Agree to Contract for Multi-State Network Participation (Business Wire)
Mar-05-26 10:15PM	Cresco Labs Inc. (CRLBF) Reports Q4 Loss, Beats Revenue Estimates (Zacks)
Mar-02-26 04:05PM	Myomo to Report Fourth Quarter 2025 Financial Results on March 9 (Business Wire)
Nov-11-25 12:02AM	Myomo Inc (MYO) Q3 2025 Earnings Call Highlights: Strong International Growth Amidst Domestic ... (GuruFocus.com) -7.31%
Nov-10-25 05:35PM	Myomo, Inc. (MYO) Reports Q3 Loss, Tops Revenue Estimates (Zacks) +7.41%
Nov-06-25 07:20AM	Prestige Consumer Healthcare (PBH) Beats Q2 Earnings and Revenue Estimates (Zacks) -5.32%
Aug-12-25 03:00PM	Myomo Inc (MYO) Q2 2025 Earnings Call Highlights: Revenue Surge Amid Rising Costs and Strategic ... (GuruFocus.com) -38.64%
Aug-11-25 07:00PM	Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Myomo Reports Second Quarter 2025 Financial and Operating Results (Business Wire)
Aug-08-25 09:32AM	Earnings To Watch: Myomo Inc (MYO) Reports Q2 2025 Result (GuruFocus.com)
Aug-04-25 04:05PM	Myomo to Report Second Quarter 2025 Financial Results on August 11 (Business Wire)
Jul-10-25 12:40AM	Myomo Reveals its $100 Revenue Goal During Investor Day (Insider Monkey)
Jun-25-25 08:56AM	Capricor (CAPR) Moves 20.4% Higher: Will This Strength Last? (Zacks)
Jun-18-25 08:30AM	Myomo Provides Highlights of Todays Investor & Analyst Day Event (Business Wire)
May-08-25 03:31AM	Myomo Inc (MYO) Q1 2025 Earnings Call Highlights: Record Revenue Surge and Strategic Innovations (GuruFocus.com) -30.58%
09:00PM	Loading…
May-07-25 09:00PM	Myomo outlines 2025 revenue target of $50M-$53M amid advancements in product and marketing strategies (Seeking Alpha)
09:00PM	Myomo, Inc. (MYO) Q1 2025 Earnings Call Transcript (Seeking Alpha)
06:25PM	Myomo, Inc. (MYO) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
05:11PM	Myomo Reports First Quarter 2025 Financial and Operating Results (Business Wire)
May-01-25 08:30AM	Myomo to Host Investor & Analyst Day Event on June 18, 2025 (Business Wire)
Apr-30-25 04:05PM	Myomo to Report First Quarter 2025 Financial Results on May 7 (Business Wire)
08:05AM	Myomo Launches the MyoPro® 2x (Business Wire)
Apr-10-25 08:30AM	Myomo Announces Upcoming Changes to its Board of Directors (Business Wire) -8.33%
Apr-09-25 06:03AM	Myomo: Balancing CMS Tailwinds With Long-Term Risks (Seeking Alpha) +5.41%
Mar-31-25 04:05PM	Myomo to Present at the 24th Annual Needham Virtual Healthcare Conference (Business Wire)
Mar-11-25 01:12PM	Q4 2024 Myomo Inc Earnings Call (Thomson Reuters StreetEvents) +40.77%
03:03AM	Myomo Inc (MYO) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Market ... (GuruFocus.com)
Mar-10-25 05:15PM	Myomo, Inc. (MYO) Reports Q4 Loss, Tops Revenue Estimates (Zacks) -9.35%
04:05PM	Myomo's Fourth Quarter Financial Results Feature Record Revenue of $12.1 Million (Business Wire)
Mar-07-25 07:06AM	What To Expect From Myomo Inc (MYO) Q4 2024 Earnings (GuruFocus.com)
Mar-03-25 04:05PM	Myomo to Report Fourth Quarter 2024 Financial Results on March 10 (Business Wire) -5.33%
Dec-05-24 07:30AM	Myomo, Inc. Prices $15.0 Million Public Offering of Common Stock (Business Wire) +11.21%
Dec-04-24 04:05PM	Myomo, Inc. Announces Proposed Public Offering of Common Stock (Business Wire)
Nov-07-24 02:22AM	Myomo Inc (MYO) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Initiatives (GuruFocus.com) +20.10%
Nov-06-24 06:00PM	Myomo, Inc. (MYO) Reports Q3 Loss, Tops Revenue Estimates (Zacks) +5.56%
04:05PM	Myomo Reports Record Third Quarter Financial and Operating Results (Business Wire)
Nov-05-24 08:07AM	Myomo Inc (MYO) Q3 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Oct-31-24 04:05PM	Myomo Announces First Private Payer Contracts for MyoPro In-network Coverage (Business Wire) -6.63%
Oct-30-24 04:05PM	Myomo to Report Third Quarter Financial Results on November 6, 2024 (Business Wire)
Oct-18-24 05:01PM	Rosalind Advisors, Inc. Expands Stake in Myomo Inc (GuruFocus.com)
Oct-09-24 05:08PM	Myomo Inc (MYO) Q2 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Expansion ... (GuruFocus.com)
04:05PM	Myomo to Participate in the 2024 Maxim Healthcare Virtual Summit (Business Wire)
Sep-12-24 08:30AM	Myomo, Inc. Announces the Launch of Myomo Academy at AOPA National Assembly (Business Wire)
Sep-05-24 04:15PM	Myomo to Participate in Two Investor Conferences in September (Business Wire)
Aug-06-24 04:05PM	Myomo Reports Second Quarter 2024 Financial Results (Business Wire) -13.33%
Jul-30-24 04:05PM	Myomo to Report Second Quarter Financial Results on August 6, 2024 (Business Wire) -5.53% +7.21%
Jul-27-24 07:40AM	The 3 Best Robotic Exoskeleton Stocks to Buy Now (InvestorPlace)
Jul-26-24 06:05PM	Myomo, Inc. (MYO): Hedge Funds Are Bullish on This Robotics Stock Now (Insider Monkey)
Jul-08-24 08:30AM	Myomo Reports Preliminary Second Quarter 2024 Revenues and Operating Metrics (Business Wire) +41.81%
Jun-11-24 10:50AM	Sidoti Events, LLC's Virtual June Small-Cap Conference (ACCESSWIRE) +9.71%
Jun-05-24 05:58PM	Myomo to Present at the Sidoti Virtual Investor Conference on June 12-13, 2024 (Business Wire)
Jun-01-24 02:42AM	Director Thomas Kirk Acquires 50,000 Shares of Myomo Inc (MYO) (GuruFocus.com)
May-17-24 07:01PM	Insider Sale: Chief Medical Officer Harry Kovelman Sells 35,426 Shares of Myomo Inc (MYO) (GuruFocus.com)
May-10-24 04:03PM	Myomo Inc Reports Q1 2024 Earnings: Revenue Up Despite Challenges (GuruFocus.com) +7.58%
01:01PM	Myomo Inc (MYO) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth Amid Financial ... (GuruFocus.com)
May-09-24 01:16PM	Myomo, Inc. (AMEX:MYO) Q1 2024 Earnings Call Transcript (Insider Monkey) -9.41%
May-08-24 04:05PM	Myomo Reports First Quarter 2024 Financial Results (Business Wire) +8.56%
May-06-24 01:19PM	Myomo Receives Reimbursements For MyoPros from CMS (MT Newswires)
08:30AM	Myomo Announces First Lump Sum Reimbursements for MyoPros Delivered to Medicare Part B Beneficiaries Under New CMS Fees (Business Wire)
May-01-24 05:21PM	Myomo to Report First Quarter Financial Results on May 8, 2024 (Business Wire) +7.95% +11.05%
Mar-28-24 04:05PM	Myomo Appoints Heather Getz to its Board of Directors (Business Wire) -6.57% -5.50%
Mar-18-24 11:00AM	Director Thomas Kirk Acquires 50,000 Shares of Myomo Inc (MYO) (GuruFocus.com)
Mar-08-24 10:15AM	Myomo, Inc. (AMEX:MYO) Q4 2023 Earnings Call Transcript (Insider Monkey) -9.37%
Mar-07-24 06:00PM	Myomo, Inc. (MYO) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Myomo Reports Fourth Quarter and Full Year 2023 Financial Results (Business Wire)
Mar-01-24 08:00AM	CMS Posts Final Medicare DMEPOS Fee Schedule Rate for the MyoPro® (Business Wire) +31.05%
Feb-29-24 04:05PM	Myomo to Report Fourth Quarter Financial Results on March 7, 2024 (Business Wire)
Jan-19-24 04:05PM	Myomo Announces Closing of $6 Million Registered Direct Offering of Common Stock Priced At-the-Market (Business Wire) -6.33%
Jan-17-24 08:05AM	Myomo Announces $6 Million Registered Direct Offering of Common Stock Priced At-the-Market (Business Wire) +7.89%
08:00AM	Myomo Reports Preliminary Fourth Quarter Revenue and Backlog (Business Wire)
Dec-20-23 08:50AM	What Makes Myomo, Inc. (MYO) a Good Fit for 'Trend Investing' (Zacks) -19.21%
Dec-12-23 07:00AM	7 Stock Winners That Are Up 1,000% or More in 2023 (InvestorPlace)
Dec-01-23 10:00AM	Top Penny Stocks for Q4 2023 (Investopedia) +7.42%
Nov-20-23 04:16PM	3 Hot Penny Stocks to Buy in Q4 for Promising Potential (InvestorPlace) +5.88%
Nov-08-23 11:47AM	Myomo, Inc. (AMEX:MYO) Q3 2023 Earnings Call Transcript (Insider Monkey) +7.39%
Nov-07-23 04:05PM	Myomo Reports Third Quarter 2023 Financial Results Featuring Record Product Revenue and Authorizations (Business Wire) +6.02%
Nov-06-23 08:30AM	CMS Posts Proposed Medicare DMEPOS Fee Schedule Rate for the MyoPro® for Review at the Upcoming HCPCS Public Meeting (Business Wire) +21.17%
Nov-02-23 10:08AM	Myomo Announces that CMS has Classified the MyoPro Orthosis Under the Brace Benefit Category (Business Wire) +8.00%
Oct-31-23 04:05PM	Myomo to Report Third Quarter Financial Results on November 7, 2023 (Business Wire) +10.62%
Aug-29-23 04:05PM	Myomo Announces Closing of $4.4 Million Public Offering (Business Wire) -6.09%
Aug-28-23 12:38PM	Is Myomo (MYO) a Hidden Gem or a Value Trap? A Comprehensive Analysis (GuruFocus.com) +18.69%
Aug-25-23 07:00AM	Myomo Announces Pricing of $4.4 Million Public Offering (Business Wire) -10.13%
Aug-24-23 07:33PM	Myomo Inc (MYO): A Hidden Gem or a Potential Value Trap? (GuruFocus.com) +18.82%
04:15PM	Myomo, Inc. Announces Proposed Public Offering (Business Wire)
04:05PM	Myomo Receives Medicare Part B Reimbursement for First MyoPro® Claims (Business Wire)

Myomo, Inc. is a wearable medical robotics company, which engages in the business of developing, designing, and producing myoelectric orthotics for people with neuromuscular disorders. It is also involved in selling products through various other sales channels including through orthotics and prosthetics providers, veterans' administration, and to distributors in certain accounts and geographic markets. The company was founded by Stephen Kelly, John McBean, Mira Sahney, and Kailas N. Narendran on September 1, 2004 and is headquartered in Burlington, MA.

PresidentMr. Paul R. Gudonis

Chief Financial OfficerMr. David A. Henry

Chief Medical OfficerDr. Harry Kovelman M.D.

Global Director of OperationsMr. Colin Anderson

Senior Director of Human ResourcesMs. Galina Shtivelman

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kovelman Harry	Chief Medical Officer	Aug 20 '26	Sale	1.73	17,250	29,896	105,983	Aug 21 06:17 PM
HARRY KOVELMAN	Officer	Aug 20 '26	Proposed Sale	1.73	17,500	30,329		Aug 20 04:04 PM
David Henry	Officer	Jul 13 '26	Proposed Sale	1.09	5,166	5,631		Jul 13 04:29 PM
Harry Kovelman	Officer	Jun 12 '26	Proposed Sale	1.20	10,442	12,530		Jun 12 04:17 PM
Micah Mitchell	Officer	Jun 12 '26	Proposed Sale	1.20	9,061	10,873		Jun 12 04:16 PM
KIRK THOMAS F	Director	Jun 05 '26	Buy	1.27	40,002	50,803	693,865	Jun 09 04:07 PM
Harry Kovelman	Officer	Jun 08 '26	Proposed Sale	1.33	7,635	10,155		Jun 08 04:12 PM
Micah Mitchell	Officer	Jun 08 '26	Proposed Sale	1.33	6,529	8,684		Jun 08 04:10 PM
KIRK THOMAS F	Director	May 28 '26	Buy	0.99	25,000	24,825	653,863	Jun 01 08:23 AM
Kovelman Harry	Chief Medical Officer	May 27 '26	Sale	1.00	20,464	20,505	120,154	May 28 09:53 PM
Kovelman Harry	Chief Medical Officer	May 28 '26	Sale	1.02	11,536	11,734	108,618	May 28 09:53 PM
HARRY KOVELMAN	Officer	May 28 '26	Proposed Sale	1.02	11,536	11,734		May 28 05:01 PM
HARRY KOVELMAN	Officer	May 27 '26	Proposed Sale	1.00	20,464	20,468		May 27 06:36 PM
KIRK THOMAS F	Director	May 18 '26	Buy	0.91	43,401	39,495	628,863	May 18 08:20 PM
KIRK THOMAS F	Director	May 15 '26	Buy	0.91	31,605	28,748	585,462	May 18 08:20 PM
Manko Joseph M. Jr.	Director	May 14 '26	Buy	0.86	170,830	146,948	2,279,408	May 18 04:59 PM
Manko Joseph M. Jr.	Director	May 15 '26	Buy	0.89	30,367	26,960	2,309,775	May 18 04:59 PM
MICAH MITCHELL	Officer	May 14 '26	Proposed Sale	0.86	90,231	77,689		May 14 06:31 PM
David Henry	Officer	Apr 13 '26	Proposed Sale	0.71	3,953	2,807		Apr 13 04:21 PM
Getz Heather C	Director	Mar 16 '26	Buy	0.70	20,000	13,972	131,754	Mar 17 05:39 PM
KIRK THOMAS F	Director	Mar 13 '26	Buy	0.71	72,000	51,113	553,857	Mar 16 06:08 PM
Getz Heather C	Director	Mar 12 '26	Buy	0.73	70,000	50,960	111,754	Mar 12 05:18 PM
KIRK THOMAS F	Director	Nov 20 '25	Buy	0.72	4,902	3,529	479,322	Nov 24 04:04 PM
KIRK THOMAS F	Director	Nov 21 '25	Buy	0.72	2,535	1,825	481,857	Nov 24 04:04 PM
Crowley Thomas Aloysius Jr.	Director	Nov 18 '25	Buy	0.73	4,000	2,938	75,748	Nov 21 07:22 PM
Crowley Thomas Aloysius Jr.	Director	Nov 19 '25	Buy	0.77	385	295	479	Nov 21 07:22 PM
KIRK THOMAS F	Director	Aug 25 '25	Buy	1.15	50,000	57,500	474,420	Aug 26 08:10 AM

Open in Screener

BFLY

Butterfly Network Inc

8.95

Aug 24 • 3:59 PM ET -0.60 (-6.28%)

8.89

Aftermarket • 7:50 PM ET -0.06 (-0.67%)

Healthcare Medical Devices USA Mid NYSE

BFLY Butterfly Network Inc daily Stock Chart

Peers: INSP IRTC NVCR GKOS BSX EW MDT TFX BAX BDX

| Held by: IWM ARKG VTI IWO VXF FESM SCHA IHI VTWO IWC

Index	RUT
Market Cap	2.43B
Enterprise Value	2.32B
Income	-74.85M
Sales	112.14M
Book/sh	0.72
Cash/sh	0.46
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	220
IPO	Jul 13, 2020

P/E	-
Forward P/E	-
PEG	-
P/S	21.65
P/B	12.50
P/C	19.48
P/FCF	-
EV/EBITDA	-
EV/Sales	20.71
Quick Ratio	3.02
Current Ratio	4.06
Debt/Eq	0.10
LT Debt/Eq	0.09
Option/Short	Yes / Yes

EPS (ttm)	-0.29
EPS next Y	-0.07
EPS next Q	-0.04
EPS this Y	2.08%
EPS next Y	36.17%
EPS next 5Y	-
EPS past 3/5Y	28.25% 58.99%
Sales past 3/5Y	9.97% 16.11%
EPS Y/Y TTM	-5.15%
Sales Y/Y TTM	28.14%
EPS Q/Q	11.49%
Sales Q/Q	39.47%
Earnings	Jul 30 BMO
EPS/Sales Surpr.	71.43% 11.84%

Insider Own	20.93%
Insider Trans	-20.36%
Inst Own	63.98%
Inst Trans	20.03%
ROA	-25.11%
ROE	-35.46%
ROIC	-36.39%
Gross Margin	52.64%
Oper. Margin	-60.03%
Profit Margin	-66.74%
SMA20	3.34%
SMA50	13.72%
SMA200	83.08%
Trades

Shs Outstand	238.00M
Shs Float	214.49M
Short Float	15.24%
Short Ratio	3.97
Short Interest	32.69M
52W High	10.05 -10.95%
52W Low	1.39 543.88%
Volatility	6.94% 8.87%
ATR (14)	0.67
RSI (14)	55.57
Beta	2.12
Rel Volume	0.57
Avg Volume	8.24M
Volume	4,665,463

Perf Week	-0.78%
Perf Month	36.02%
Perf Quarter	100.22%
Perf Half Y	204.42%
Perf YTD	135.53%
Perf Year	488.82%
Perf 3Y	423.39%
Perf 5Y	-24.41%
Perf 10Y	-
Recom	1.00
Target Price	10.50
Prev Close	9.55
Price	8.95
Change %	-6.28%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-01-25	Downgrade	Oppenheimer	Outperform → Perform
Jul-01-25	Initiated	Craig Hallum	Buy	$3
Mar-17-25	Initiated	William Blair	Outperform
Sep-10-24	Initiated	Lake Street	Buy	$3
Mar-29-23	Initiated	UBS	Neutral	$2.25
Nov-29-22	Initiated	Oppenheimer	Outperform	$4.50
Oct-04-22	Initiated	B. Riley Securities	Buy	$9.50
Dec-17-21	Initiated	UBS	Neutral	$7
Jun-21-21	Initiated	Cowen	Outperform	$20

Aug-11-26 08:05AM	Butterfly Network Congratulates Dr. Erica Schwartz on Confirmation as CDC Director (Business Wire)
Jul-31-26 10:54AM	Butterfly Network CEO Joe DeVivo Reveals What Fueled Firms 39% Annual Growth (NYSE) -12.97%
Jul-30-26 10:34PM	Butterfly Network, Inc. Q2 2026 Earnings Call Summary (Moby) +15.07%
03:01PM	Butterfly Network Inc (BFLY) (Q2 2026) Earnings Call Highlights: Record Revenue and Surging ... (GuruFocus.com)
06:30AM	Butterfly Network Reports Second Quarter 2026 Financial Results (Business Wire)
08:05AM	Loading…
Jul-16-26 08:05AM	Butterfly Network to Report Second Quarter 2026 Financial Results on July 30, 2026 (Business Wire)
Jul-02-26 08:05AM	Butterfly Network Expands its Handheld Ultrasound Availability into Brazil (Business Wire)
Jun-25-26 05:02PM	Butterfly Network's Embedded Partner Aleph Neuro Unveils Stunning Brain Images (Business Wire) +10.85%
Jun-22-26 01:39AM	BFLY Stock Soars, Wows Michael Burry As Midjourney Taps Butterfly Tech For AI-Powered Full-Body Scanner (Stocktwits) -18.31%
Jun-18-26 03:02PM	This AI company wants to replace MRIs with a 60-second dip in the spa. Can that really work? (MarketWatch) +55.87%
11:56AM	BFLY Stock Hits Four-Year High What Is Butterfly Networks Connection With AI Startup Midjourney? (Stocktwits)
09:56AM	Butterfly Network Shares Jump as Midjourney Unveils Imaging Platform Built on Ultrasound-on-Chip Technology (BFLY) (InvestorsHub)
08:05AM	Butterfly Network Provides Commentary on Midjourney Medicals Full Body Ultrasound Scanner Announcement (Business Wire)
Jun-16-26 09:11AM	16 Million People, One Underserved Disease: The AI Imaging Push to Close the Congenital Heart Gap (PR Newswire)
Jun-11-26 08:05AM	Butterfly Network to Participate in TD Cowens Medical Devices Emerging Growth Call Series on June 18, 2026 (Business Wire) +5.38%
04:05PM	Loading…
May-21-26 04:05PM	Butterfly Network to Participate in the William Blair 46th Annual Growth Stock Conference (Business Wire)
May-19-26 08:55AM	Cardiac AI Diagnostics Stack Validation Wins Across Regulatory and Commercial Fronts (PR Newswire) +6.77%
May-08-26 08:05AM	Butterfly Network Appoints Caroll H. Neubauer to Board of Directors (Business Wire)
May-07-26 08:05AM	Butterfly Network to Present at the Bank of America Securities 2026 Global Healthcare Conference (Business Wire) -6.81%
May-01-26 08:30AM	Butterfly Network, Inc. Q1 2026 Earnings Call Summary (Moby) +12.73%
Apr-30-26 06:30AM	Butterfly Network Reports First Quarter 2026 Financial Results (Business Wire)
Apr-29-26 09:23AM	Butterfly Network Inc (BFLY) Q1 2026 Earnings Report Preview: What To Look For (GuruFocus.com)
Apr-25-26 10:05AM	Forget Neuralink: The Real Brain Tech Trade Has 10 Names Youve Never Heard (InvestorPlace)
Apr-21-26 08:05AM	Butterfly Network Appoints Arun Nagdev, MD as Chief Medical Officer - POCUS (Business Wire)
Apr-16-26 08:05AM	Butterfly Network to Report First Quarter 2026 Financial Results on April 30, 2026 (Business Wire) +8.85%
Mar-30-26 08:00AM	Butterfly Network Secures First FDA Clearance for Blind Sweep Ultrasound AI Tool, Marking a Major Stride for Women's Health (Business Wire)
Mar-10-26 08:05AM	Butterfly Network Appoints David Horsley as Senior Vice President, Innovation - Butterfly Embedded (Business Wire)
Mar-09-26 08:11PM	Butterfly Network (BFLY) Supplements Core Business With Additional Revenue Stream (Insider Monkey)
Mar-08-26 10:01AM	Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet (Benzinga)
Mar-03-26 12:19PM	Hospital Networks Turn to AI-Enhanced Cardiac Imaging to Cut Costs and Improve Outcomes (PR Newswire)
08:59AM	Loading…
Feb-28-26 08:59AM	Butterfly Network price target raised to $6 from $4.50 at TD Cowen (TipRanks)
Feb-27-26 06:17PM	Butterfly Network Q4 Earnings Call Highlights (MarketBeat) -18.84%
04:22AM	New Strong Sell Stocks for February 27th (Zacks)
Feb-26-26 04:12PM	Butterfly Network Inc (BFLY) Q4 2025 Earnings Call Highlights: Record Revenue Growth and ... (GuruFocus.com) +50.65%
09:45AM	Butterfly Network, Inc. (BFLY) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
06:30AM	Butterfly Network Reports Fourth Quarter 2025 Financial Results (Business Wire)
Feb-25-26 07:34AM	Butterfly Network Inc (BFLY) Q4 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com) +5.08%
Feb-23-26 07:25PM	Claritev Corporation (CTEV) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
Feb-17-26 08:05AM	Butterfly Network to Participate at TD Cowen 46th Annual Health Care Conference on March 3, 2026 (Business Wire)
Feb-13-26 11:44AM	Is Butterfly Network (BFLY) One of the Best Strong Buy Penny Stocks to Invest In? (Insider Monkey)
Feb-10-26 09:47AM	Jim Cramer on Butterfly Network (BFLY): "Too Hard for This Guy, Just Too Hard" (Insider Monkey)
08:01AM	Butterfly Network Achieves GovRAMP and TX-RAMP Information Security Certifications (Business Wire)
Feb-03-26 08:01AM	Butterfly Network to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 (Business Wire)
Jan-27-26 10:14AM	AI Medical Imaging Revolution: Software-Native Tech Disrupts $45B Market (PR Newswire)
Jan-21-26 08:45AM	Butterfly Network price target raised to $5.50 from $4 at Lake Street (TipRanks) +7.02%
Jan-16-26 11:56AM	Bedside Breakthrough: AI Brings MRI-Precision to Every Clinic (PR Newswire) -8.57%
Jan-14-26 09:40AM	Is Assertio (ASRT) Stock Outpacing Its Medical Peers This Year? (Zacks) +12.50%
Jan-12-26 08:01AM	Butterfly Network Reports Preliminary, Unaudited Fourth Quarter 2025 Revenue Growth of at least 17% Year over Year (Business Wire) +5.69%
Jan-07-26 12:24PM	BFLY to Extend 3D Imaging Capabilities to Butterfly Garden Developers (Zacks)
Jan-06-26 08:05AM	Butterfly Network to Extend its Proprietary 3D Imaging Capabilities to Butterfly Garden Developers (Business Wire)
Dec-31-25 09:36AM	GlobalFoundries downgraded, TeraWulf upgraded: Wall Street's top analyst calls (The Fly)
Dec-18-25 08:05AM	Butterfly Network to Present at the 44th Annual J.P. Morgan Healthcare Conference (Business Wire) +8.83%
Dec-11-25 11:40PM	Craig-Hallum Maintains a Buy on Butterfly Network (BFLY) (Insider Monkey)
Dec-09-25 09:45AM	Top Insider Purchases in December Signal Market Confidence (24/7 Wall St.)
Nov-26-25 03:34PM	Staar Surgical, Gold Royalty See Activist Action (Barrons.com) -9.14%
Nov-24-25 07:53AM	TEM vs. BFLY: Which Stock Offers Greater Upside Amid Health Tech Boom? (Zacks) +23.77%
Nov-21-25 08:05AM	Butterfly Network to Participate at the 8th Annual Evercore Healthcare Conference (Business Wire) +14.22%
Nov-20-25 01:27AM	Butterfly Network Launches Compass AI: Enterprise Platform to Boost POCUS Documentation Compliance, Revenue (Insider Monkey)
Nov-18-25 11:39AM	BFLY Stock Down Despite Launching Compass AI to Drive POCUS Programs (Zacks)
Nov-17-25 08:05AM	Butterfly Network Launches Compass AI to Power the Next Generation of POCUS Program Management (Business Wire) -7.08%
Oct-31-25 03:02PM	Butterfly Network Inc (BFLY) Q3 2025 Earnings Call Highlights: Navigating Growth Amid Inventory ... (GuruFocus.com) +31.86%
11:05AM	BFLY's Q3 Earnings Miss Estimates, Revenues Surpass, Stock Climbs (Zacks)
06:30AM	Butterfly Network Reports Third Quarter 2025 Financial Results (Business Wire)
Oct-30-25 09:33AM	Earnings To Watch: Butterfly Network Inc (BFLY) Reports Q3 2025 Result (GuruFocus.com) -5.12%
Oct-29-25 08:05AM	Butterfly Network to Participate at UBS Global Healthcare Conference 2025 (Business Wire)
Oct-27-25 08:05AM	Butterfly Network Strengthens Global Information Security Posture with ISO 27001, SOC-2 Type 2, C5 Germany, and NHS DSPT Accreditations (Business Wire)
Oct-23-25 08:30AM	Investors Turn to AI-Driven Imaging Firms Targeting High-Growth Breast Cancer Market (PR Newswire)
Oct-22-25 09:20AM	BFLY Q3 Earnings Preview: Strategic Progress Likely to Support Growth (Zacks) -5.33%
Oct-17-25 08:05AM	Butterfly Network to Report Third Quarter 2025 Financial Results on October 31, 2025 (Business Wire) -5.36%
Oct-10-25 08:44AM	TEM Expands Partnership With Northwestern Medicine Amid AI Boom (Zacks) -11.28%
Oct-09-25 04:05PM	Butterfly Network Appoints John Doherty as Chief Financial Officer (Business Wire)
Oct-06-25 09:17AM	Zacks.com featured highlights include Public Service Enterprise Group, Genpact, The Progressive, Exelon and Butterfly Network (Zacks) +9.87%
07:45AM	Butterfly Network Launches First-to-Market Artificial Intelligence Gestational Age Tool in Sub-Saharan Africa to Improve Maternal Health (Business Wire)
Oct-03-25 09:06AM	Bet on 5 Top-Ranked Stocks With Rising P/E (Zacks) +18.88%
Sep-21-25 09:15AM	Butterfly Network Gains Investor Confidence with Record Results (Insider Monkey)
Sep-18-25 04:05PM	Butterfly Network Named to TIME's List of the World's Top HealthTech Companies 2025 (Business Wire) +15.95%
Sep-17-25 02:18PM	TD Cowen Remains Bullish on Butterfly (BFLY), iQ3 Results Bolster Adoption Potential (Insider Monkey)
Sep-12-25 03:35AM	The Zacks Analyst Blog Highlights Butterfly Network, Omnicell, NVIDIA, Palantir and IBM (Zacks)
Sep-11-25 03:00PM	NVIDIA, AI & Quantum Leaders Drive Health Tech: 2 Stocks to Buy (Zacks)
Sep-09-25 08:00AM	Butterfly Network Appoints Victor Ku as Chief Technology Officer (Business Wire)
Sep-05-25 02:11PM	Rutgers Robert Wood Johnson Medical School Study Published in JAMA Confirms Butterfly-Enabled POCUS Program Heavily Focused on LUNG US with AI Assistance Reduces Stay and Cost (Business Wire)
Aug-26-25 08:54AM	$504 Billion AI Healthcare Revolution Accelerates as Corporate Giants Launch Next-Gen Platforms (PR Newswire)
Aug-25-25 03:00PM	Tempus AI or Butterfly: Which AI Health Tech Stock is a Buy Now? (Zacks)
Aug-19-25 08:05AM	Butterfly Network Joins Research Project Studying the Impact of AI-Assisted POCUS on Early Tuberculosis Detection in Sub-Saharan Africa (Business Wire)
Aug-17-25 11:41PM	Butterfly Network Advances AI-Powered Ultrasound for Aortic Screening (Insider Monkey)
Aug-13-25 12:08PM	TD Cowen Reiterates a Buy Rating on Butterfly Network (BFLY), Sets a PT of $3.50 (Insider Monkey)
Aug-12-25 09:51PM	Cardiosense appoints John Martin as chief medical officer (MedTech Dive)
11:09AM	Healthcare AI Market Explodes 38.5% Annually as Diagnostics Gain FDA Traction (PR Newswire)
Aug-06-25 12:00PM	What Makes Butterfly Network (BFLY) a New Buy Stock (Zacks)
Aug-05-25 08:05AM	Butterfly Network Advances AI-Powered Aortic Valve and Aorta Screening with New Research and Training Tools (Business Wire)
Aug-02-25 03:06AM	Butterfly Network Inc (BFLY) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic ... (GuruFocus.com)
Aug-01-25 07:47AM	CORRECTING and REPLACING Butterfly Network Reports Second Quarter 2025 Financial Results (Business Wire) -18.13%
07:40AM	Butterfly Network, Inc. (BFLY) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
06:30AM	Butterfly Network Reports Second Quarter 2025 Financial Results (Business Wire)
Jul-31-25 09:30AM	Butterfly Network Inc (BFLY) Q2 2025 Earnings Report Preview: What To Look For (GuruFocus.com) -5.52%
Jul-18-25 08:05AM	Butterfly Network to Report Second Quarter 2025 Financial Results on August 1, 2025 (Business Wire)
Jul-15-25 09:00AM	Overture Life Appoints Former Butterfly Network Executive Matt Combs as Chief Commercial Officer to Lead Scale-up of IVF Automation Technology as Demand Surges Worldwide (Business Wire)
Jul-02-25 10:07PM	Butterfly Network, Inc. (BFLY) Gains Analyst Confidence Amid EU Review (Insider Monkey)
Jun-09-25 08:00AM	Butterfly Networks RoHS Lead Exemption Revocation Request Progresses to Stakeholder and Consultant Assessment (Business Wire)
Jun-04-25 02:36PM	AI in Healthcare Just Crossed a Tipping Point. Investors Are Watching These Names (PR Newswire)

Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. It develops and provides a whole-body portable ultrasound scanner called the iQ Device and related hosted, web-based application, application programming interfaces and platform services, which the firm offer to physicians or other licensed health care providers. Its products include iQ+ Ultrasound, Butterfly Enterprise and iQ Vet. The company was founded by Jonathan M. Rothberg on January 25, 2011 and is headquartered in Burlington, MA.

CEOMr. Joseph M. DeVivo

Founder & DirectorDr. Jonathan M. Rothberg Ph.D.

Executive VP & CFOMr. John N. Doherty

Executive VP & Chief Business OfficerMr. Steven Cashman

Senior VP & CTOMr. Victor Ku

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ROBBINS LARRY	Director	Aug 13 '26	Sale	9.24	890,533	8,224,688	4,371,387	Aug 17 07:01 PM
ROBBINS LARRY	Director	Aug 14 '26	Sale	8.70	824,700	7,172,663	3,546,687	Aug 17 07:01 PM
ROBBINS LARRY	Director	Aug 17 '26	Sale	8.97	582,500	5,225,142	2,964,187	Aug 17 07:01 PM
Phanstiel S. Louise	Director	Aug 14 '26	Buy	8.68	115,200	999,510	300,461	Aug 17 04:51 PM
Caezza Nicholas	Deputy General Counsel	Aug 11 '26	Sale	9.75	10,000	97,500	300,307	Aug 12 05:03 PM
DEVIVO JOSEPH	President & CEO	Aug 10 '26	Sale	10.01	68,346	684,075	7,603,700	Aug 12 04:32 PM
Caezza Nicholas	Officer	Aug 11 '26	Proposed Sale	9.75	10,000	97,500		Aug 11 01:46 PM
DEVIVO JOSEPH	Officer	Aug 10 '26	Proposed Sale	10.01	68,346	684,082		Aug 10 04:44 PM
Carfora Dawn	Officer	Aug 10 '26	Proposed Sale	9.75	8,770	85,512		Aug 10 11:24 AM
Carlson Megan	CAO and SVP, Finance	Jul 31 '26	Sale	7.86	68,852	541,383	425,889	Aug 04 04:41 PM
ROBBINS LARRY	Director	Jul 31 '26	Sale	7.39	1,720,129	12,716,054	12,614,926	Aug 03 06:11 PM
ROBBINS LARRY	Director	Aug 03 '26	Sale	8.10	156,163	1,265,670	12,458,763	Aug 03 06:11 PM
ROBBINS LARRY	Director	Jul 31 '26	Proposed Sale	7.11	1,876,292	13,340,436		Jul 31 09:46 PM
Carlson Megan	Officer	Jul 31 '26	Proposed Sale	7.86	68,852	541,406		Jul 31 11:40 AM
ROTHBERG JONATHAN M	Director	Jul 22 '26	Sale	6.47	659,913	4,269,505	0	Jul 24 04:57 PM
ROTHBERG JONATHAN M	Director	Jul 22 '26	Proposed Sale	6.47	659,913	4,270,000		Jul 22 06:08 PM
ROTHBERG JONATHAN M	Director	Jul 17 '26	Sale	6.60	1,195,857	7,887,753	54,143	Jul 21 07:52 PM
ROTHBERG JONATHAN M	Director	Jul 20 '26	Sale	6.61	1,177,276	7,786,268	72,724	Jul 21 07:52 PM
ROTHBERG JONATHAN M	Director	Jul 21 '26	Sale	6.74	753,320	5,074,288	496,680	Jul 21 07:52 PM
ROTHBERG JONATHAN M	Director	Jul 21 '26	Proposed Sale	6.73	753,320	5,070,000		Jul 21 04:59 PM
Ku Victor	Chief Technology Officer	Jul 20 '26	Sale	6.56	48,540	318,422	1,015,099	Jul 21 04:26 PM
Doherty John N.	EVP, CFO	Jul 20 '26	Sale	6.56	57,136	374,812	1,397,276	Jul 21 04:23 PM
DEVIVO JOSEPH	President & CEO	Jul 20 '26	Sale	6.56	211,798	1,389,395	7,672,046	Jul 21 04:21 PM
ROTHBERG JONATHAN M	Director	Jul 20 '26	Proposed Sale	6.62	1,177,276	7,790,000		Jul 20 05:09 PM
Doherty John N.	Officer	Jul 20 '26	Proposed Sale	6.56	1	7		Jul 20 04:20 PM
DEVIVO JOSEPH	Officer	Jul 20 '26	Proposed Sale	6.56	211,798	1,389,353		Jul 20 03:12 PM
Doherty John N.	Officer	Jul 20 '26	Proposed Sale	6.56	57,135	374,794		Jul 20 03:10 PM
Ku Victor	Officer	Jul 20 '26	Proposed Sale	6.56	48,540	318,413		Jul 20 03:10 PM
ROTHBERG JONATHAN M	Director	Jul 17 '26	Proposed Sale	6.59	1,195,857	7,880,000		Jul 17 04:48 PM
ROTHBERG JONATHAN M	Director	Jul 15 '26	Sale	7.32	1,730,319	12,670,780	359,748	Jul 16 08:18 PM
ROTHBERG JONATHAN M	Director	Jul 16 '26	Sale	7.09	1,213,634	8,603,330	36,366	Jul 16 08:18 PM
ROTHBERG JONATHAN M	Director	Jul 14 '26	Sale	7.72	815,632	6,294,885	2,090,067	Jul 16 08:18 PM
ROTHBERG JONATHAN M	Director	Jul 16 '26	Sale	7.09	253,867	1,799,638	105,881	Jul 16 08:18 PM
ROTHBERG JONATHAN M	Director	Jul 16 '26	Proposed Sale	7.09	1,467,501	10,400,000		Jul 16 05:43 PM
ROTHBERG JONATHAN M	Director	Jul 15 '26	Proposed Sale	7.32	1,730,319	12,670,000		Jul 15 05:39 PM
ROTHBERG JONATHAN M	Director	Jul 14 '26	Proposed Sale	7.71	815,632	6,290,000		Jul 14 05:57 PM
Ku Victor	Chief Technology Officer	Jul 07 '26	Sale	7.87	35,649	280,665	1,063,639	Jul 08 04:32 PM
Doherty John N.	EVP, CFO	Jul 07 '26	Sale	7.87	55,229	434,818	1,454,412	Jul 08 04:29 PM
DEVIVO JOSEPH	President & CEO	Jul 07 '26	Sale	7.87	204,725	1,611,800	7,883,844	Jul 08 04:25 PM
Carlson Megan	CAO and SVP, Finance	Jul 02 '26	Sale	7.96	41,303	328,937	465,906	Jul 07 04:10 PM
DEVIVO JOSEPH	Officer	Jul 07 '26	Proposed Sale	7.87	204,725	1,611,820		Jul 07 03:22 PM
Ku Victor	Officer	Jul 07 '26	Proposed Sale	7.87	35,649	280,668		Jul 07 03:17 PM
Doherty John N.	Officer	Jul 07 '26	Proposed Sale	7.87	55,229	434,823		Jul 07 03:09 PM
Carlson Megan	Officer	Jul 02 '26	Proposed Sale	7.96	41,303	328,916		Jul 02 03:09 PM
Carfora Dawn	Officer	Jun 29 '26	Proposed Sale	9.33	176,301	1,644,607		Jun 29 04:27 PM
Carfora Dawn	Director	Jun 22 '26	Proposed Sale	8.22	80,434	660,930		Jun 22 10:24 AM
Cashman Steve	Chief Business Officer	Jun 08 '26	Sale	4.66	294,680	1,373,209	1,630,407	Jun 09 05:19 PM
Cashman Steve	Chief Business Officer	Jun 05 '26	Sale	4.96	104,781	520,133	1,925,087	Jun 09 05:19 PM
Cashman Steve	Officer	Jun 08 '26	Proposed Sale	4.69	184,680	865,448		Jun 08 01:06 PM
Cashman Steve	Officer	Jun 08 '26	Proposed Sale	4.62	110,000	507,876		Jun 08 12:30 PM
Cashman Steve	Officer	Jun 05 '26	Proposed Sale	4.96	104,781	520,174		Jun 05 04:17 PM
Caezza Nicholas	Deputy General Counsel	Jun 02 '26	Sale	4.52	1,733	7,831	310,307	Jun 04 04:02 PM
Caezza Nicholas	Officer	Jun 02 '26	Proposed Sale	4.52	1,733	7,831		Jun 02 03:17 PM
Carlson Megan	CAO and SVP, Finance	May 01 '26	Sale	4.75	110,422	524,394	507,209	May 05 04:05 PM
Cashman Steve	Chief Business Officer	Apr 29 '26	Sale	4.91	147,518	724,166	2,029,868	May 01 04:04 PM
Carlson Megan	Officer	May 01 '26	Proposed Sale	4.75	110,422	524,402		May 01 02:04 PM
Cashman Steve	Officer	Apr 29 '26	Proposed Sale	4.91	147,518	724,151		Apr 29 03:42 PM
Cashman Steve	Chief Business Officer	Apr 16 '26	Sale	5.22	200,000	1,044,400	2,177,386	Apr 17 04:02 PM
Cashman Steve	Officer	Apr 16 '26	Proposed Sale	5.22	200,000	1,044,483		Apr 16 04:14 PM
DEVIVO JOSEPH	President & CEO	Mar 05 '26	Sale	3.71	482,149	1,788,291	8,030,899	Mar 06 04:05 PM
DEVIVO JOSEPH	Officer	Mar 05 '26	Proposed Sale	3.71	482,149	1,788,484		Mar 05 04:42 PM
Cashman Steve	Chief Business Officer	Mar 03 '26	Sale	3.71	42,540	157,908	2,377,386	Mar 04 04:11 PM
DEVIVO JOSEPH	President & CEO	Mar 03 '26	Sale	3.71	161,275	598,653	8,513,048	Mar 04 04:11 PM
Caezza Nicholas	Deputy General Counsel	Mar 03 '26	Sale	3.71	14,209	52,744	312,040	Mar 04 04:11 PM
Carlson Megan	CAO and SVP, Finance	Mar 03 '26	Sale	3.71	41,978	155,822	617,631	Mar 04 04:11 PM
Carlson Megan	Officer	Mar 03 '26	Proposed Sale	3.71	41,978	155,831		Mar 03 04:58 PM
DEVIVO JOSEPH	Officer	Mar 03 '26	Proposed Sale	3.71	161,275	598,685		Mar 03 04:54 PM
Caezza Nicholas	Officer	Mar 03 '26	Proposed Sale	3.71	14,209	52,747		Mar 03 04:11 PM
Cashman Steve	Officer	Mar 03 '26	Proposed Sale	3.71	42,540	157,917		Mar 03 03:57 PM
Cashman Steve	Chief Business Officer	Feb 26 '26	Sale	4.35	250,000	1,087,000	1,931,884	Mar 02 04:23 PM
Cashman Steve	Officer	Feb 26 '26	Proposed Sale	4.35	250,000	1,087,050		Feb 26 04:25 PM
Doherty John N.	EVP, CFO	Jan 07 '26	Sale	3.98	60,182	239,524	1,234,688	Jan 09 04:02 PM
ROTHBERG JONATHAN M	Director	Jan 07 '26	Sale	4.14	452,729	1,874,253	335,834	Jan 08 06:14 PM
ROTHBERG JONATHAN M	Director	Jan 06 '26	Sale	4.03	351,617	1,416,806	788,563	Jan 08 06:14 PM
ROTHBERG JONATHAN M	Director	Jan 08 '26	Sale	4.18	335,834	1,404,525	0	Jan 08 06:14 PM
ROTHBERG JONATHAN M	Director	Jan 08 '26	Proposed Sale	4.18	335,834	1,404,525		Jan 08 04:53 PM
ROTHBERG JONATHAN M	Director	Jan 07 '26	Proposed Sale	4.14	452,729	1,874,253		Jan 07 04:49 PM
Ku Victor	Chief Technology Officer	Jan 05 '26	Sale	3.82	35,968	137,398	811,962	Jan 07 04:06 PM
Doherty John N.	Officer	Jan 07 '26	Proposed Sale	3.98	60,182	239,494		Jan 07 03:13 PM
ROTHBERG JONATHAN M	Director	Jan 06 '26	Proposed Sale	4.03	351,617	1,416,805		Jan 06 05:22 PM
Ku Victor	Officer	Jan 05 '26	Proposed Sale	3.82	35,968	137,416		Jan 05 03:11 PM
ROTHBERG JONATHAN M	Director	Dec 23 '25	Sale	4.01	44,781	179,424	1,157,764	Dec 29 04:05 PM
ROTHBERG JONATHAN M	Director	Dec 26 '25	Sale	4.01	14,911	59,790	1,140,180	Dec 29 04:05 PM
ROTHBERG JONATHAN M	Director	Dec 24 '25	Sale	4.00	2,673	10,692	1,155,091	Dec 29 04:05 PM
ROTHBERG JONATHAN M	Director	Dec 26 '25	Proposed Sale	4.01	14,911	59,790		Dec 29 02:52 PM
ROTHBERG JONATHAN M	Director	Dec 24 '25	Proposed Sale	4.00	2,673	10,692		Dec 29 02:50 PM
ROTHBERG JONATHAN M	Director	Dec 23 '25	Proposed Sale	4.01	44,781	179,424		Dec 23 04:51 PM
ROTHBERG JONATHAN M	Director	Dec 15 '25	Sale	3.16	601,308	1,902,659	196,662	Dec 17 05:56 PM
ROTHBERG JONATHAN M	Director	Dec 16 '25	Sale	3.14	284,986	893,830	0	Dec 17 05:56 PM
Phanstiel S. Louise	Director	Dec 15 '25	Buy	3.08	185,261	571,160	185,261	Dec 17 04:10 PM
ROTHBERG JONATHAN M	Director	Dec 16 '25	Proposed Sale	3.14	284,986	893,830		Dec 16 04:41 PM
ROBBINS LARRY	Director	Dec 11 '25	Buy	3.02	21,370	64,471	14,335,055	Dec 15 06:20 PM
ROTHBERG JONATHAN M	Director	Dec 15 '25	Proposed Sale	3.16	601,308	1,902,658		Dec 15 04:41 PM
ROTHBERG JONATHAN M	Director	Dec 10 '25	Sale	3.13	288,918	905,238	255,976	Dec 12 06:58 PM
ROTHBERG JONATHAN M	Director	Dec 12 '25	Sale	3.08	193,293	595,420	0	Dec 12 06:58 PM
ROTHBERG JONATHAN M	Director	Dec 11 '25	Sale	3.08	123,354	380,128	132,622	Dec 12 06:58 PM
ROTHBERG JONATHAN M	Director	Dec 12 '25	Proposed Sale	3.08	193,293	596,270		Dec 12 04:56 PM
ROTHBERG JONATHAN M	Director	Dec 11 '25	Proposed Sale	3.08	123,354	380,127		Dec 11 04:50 PM
ROTHBERG JONATHAN M	Director	Dec 08 '25	Sale	3.27	769,327	2,517,776	0	Dec 10 08:27 PM
ROTHBERG JONATHAN M	Director	Dec 09 '25	Sale	3.11	176,070	546,768	111,031	Dec 10 08:27 PM

TELA

TELA Bio Inc

MYO

Myomo Inc

BFLY

Butterfly Network Inc

Upgrade your Finviz experience